3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
57
Carcinoma, Hepatocellular
45
Colorectal Neoplasms
18
Esophageal Squamous Cell Carcinoma
10
Cholangiocarcinoma
10
Esophageal Neoplasms
9
Advanced Gastric Cancer
9
Biliary Tract Neoplasms
8
Pancreatic Neoplasms
6
Liver Neoplasms
5
Neoplasms
3
Neoplasm Metastasis
3
Gastrointestinal Neoplasms
3
Gastric Adenocarcinoma
3
Digestive System Neoplasms
3
Recurrence
2
Metastatic Gastric Adenocarcinoma
2
Locally Advanced Gastric Cancer
2
Gastrointestinal Stromal Tumors
2
Advanced Esophagus Cancer
2
Uterine Cervical Neoplasms
1
Stomach Diseases
1
Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
1
Peritoneal Metastases From Gastric Cancer
1
Ovarian Neoplasms
1
Locally Advanced or Metastatic Gastric Adenocarcinoma
1
Intestinal Neoplasms
1
Immunotherapy Gastrict Cancer
1
Immunotherapy
1
Hepatic Metastasis of Colorectal Cancer
1
Interventions
Gemcitabine
9
130-nm albumin-bound paclitaxel
6
S 1 (combination)
4
Albumin-Bound Paclitaxel
4
toripalimab
3
Taxes
3
Nivolumab
2
Injections
2
Drug Therapy
2
surufatinib
1
penpulimab
1
pegylated granulocyte colony-stimulating factor
1
paricalcitol
1
nimotuzumab
1
irinotecan sucrosofate
1
gimeracil
1
fluzoparib
1
envafolimab
1
endostar protein
1
conteltinib
1
camrelizumab
1
cabiralizumab
1
apatinib
1
Tegafur
1
Simvastatin
1
Radiosurgery
1
Paclitaxel
1
Oxaliplatin
1
Metformin
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Pancreatic Cancer
×
apatinib
×
Gastrointestinal
×
Clear all
NCT03662035
2018-09-19
ASPC
Changzhou No.2 People's Hospital
Phase 2
Unknown
30 enrolled